[{"start_date": "2025-07-01", "end_date": "2025-09-30", "filing_date": "2025-11-12", "acceptance_datetime": "2025-11-12T21:15:54Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2025", "cik": "0001672619", "sic": "2834", "tickers": ["ELVN", "IMRA"], "company_name": "Enliven Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-25-277619", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-25-277619/files/elvn-20250930_htm.xml", "financials": {"income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -20148000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -20148000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -25096000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_earnings_per_share": {"value": -0.32, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_parent": {"value": -20148000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 18225000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "nonoperating_income_loss": {"value": 4948000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "basic_average_shares": {"value": 62093795.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "other_operating_expenses": {"value": 6871000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -20148000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_earnings_per_share": {"value": -0.32, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_average_shares": {"value": 62093795.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_expenses": {"value": 25096000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -20148000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -19750000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -19750000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 398000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"other_current_liabilities": {"value": 13221000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_assets": {"value": 8192000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 103000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 476122000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 490875000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 14753000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 476122000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 399000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_assets": {"value": 5083000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "accounts_payable": {"value": 1429000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 7793000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 14650000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 490875000.0, "unit": "USD", "label": "Assets", "order": 100}, "cash": {"value": 477600000.0, "unit": "USD", "label": "Cash", "order": 210}, "current_assets": {"value": 482683000.0, "unit": "USD", "label": "Current Assets", "order": 200}}}}, {"start_date": "2025-04-01", "end_date": "2025-07-01", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0001672619", "sic": "2834", "tickers": ["ELVN"], "company_name": "Enliven Therapeutics, Inc.", "financials": {"balance_sheet": {"equity_attributable_to_parent": {"value": 488472000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": -488472000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": -488472000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 488472000.0, "unit": "USD", "label": "Equity", "order": 1400}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -161000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -25335000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -25335000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": -25335000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -25335000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss": {"value": -25335000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "filing_date": "2025-05-14", "acceptance_datetime": "2025-05-14T20:15:33Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0001672619", "sic": "2834", "tickers": ["ELVN"], "company_name": "Enliven Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-071412", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-071412/files/elvn-20250331_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -28615000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -71000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -28615000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -28544000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -28544000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_average_shares": {"value": 50051283.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "basic_earnings_per_share": {"value": -0.57, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_earnings_per_share": {"value": -0.57, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "other_operating_expenses": {"value": 6798000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "nonoperating_income_loss": {"value": 3149000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_loss_from_continuing_operations_after_tax": {"value": -28544000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -31693000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -28544000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "diluted_average_shares": {"value": 50051283.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -28544000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 31693000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 24895000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}}, "balance_sheet": {"other_current_liabilities": {"value": 12410000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 404000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 302570000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "cash": {"value": 289600000.0, "unit": "USD", "label": "Cash", "order": 210}, "other_noncurrent_assets": {"value": 7848000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 294318000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 8252000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 302570000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 13972000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_assets": {"value": 4718000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "liabilities": {"value": 14274000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 288296000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 1562000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": 288296000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 1427000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 234000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -22466000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 234000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -24127000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 1427000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -22466000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -24127000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}}}, {"start_date": "2024-10-01", "end_date": "2024-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2024", "cik": "0001672619", "sic": "2834", "tickers": ["ELVN"], "company_name": "Enliven Therapeutics, Inc.", "financials": {"balance_sheet": {"liabilities": {"value": 15915000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 1342000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 14573000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "cash": {"value": 313400000.0, "unit": "USD", "label": "Cash", "order": 210}, "assets": {"value": 325760000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 7633000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_assets": {"value": 4727000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "fixed_assets": {"value": 458000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity": {"value": 309845000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_noncurrent_assets": {"value": 7175000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 15915000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 325760000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 318127000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 309845000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}, "income_statement": {"research_and_development": {"value": 20724000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -23180000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "basic_earnings_per_share": {"value": -0.45999999999999996, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_after_tax": {"value": -23180000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -23180000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -23180000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -26896000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "diluted_earnings_per_share": {"value": -0.45999999999999996, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_before_tax": {"value": -23180000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_average_shares": {"value": 935362, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_average_shares": {"value": 935362, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 26896000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "nonoperating_income_loss": {"value": 3716000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "other_operating_expenses": {"value": 6172000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -23367000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -23367000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 65657000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 39972000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 727000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 727000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 39972000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 23496000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -17203000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -17203000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 23496000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}}}, {"start_date": "2024-07-01", "end_date": "2024-09-30", "filing_date": "2024-11-13", "acceptance_datetime": "2024-11-13T21:15:24Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2024", "cik": "0001672619", "sic": "2834", "tickers": ["ELVN"], "company_name": "Enliven Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-126332", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-126332/files/elvn-20240930_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -22775000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 381000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -22775000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -12193000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 1117000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 1117000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 14826000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -12193000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 3750000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 14826000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 3750000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "income_statement": {"research_and_development": {"value": 21258000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_expenses": {"value": 27068000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -23156000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_earnings_per_share": {"value": -0.48, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_after_tax": {"value": -23156000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_average_shares": {"value": 48267458.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_before_tax": {"value": -23156000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_average_shares": {"value": 48267458.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "other_operating_expenses": {"value": 5810000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "nonoperating_income_loss": {"value": 3912000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "diluted_earnings_per_share": {"value": -0.48, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -23156000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -23156000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_income_loss": {"value": -27068000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}}, "balance_sheet": {"cash": {"value": 291800000.0, "unit": "USD", "label": "Cash", "order": 210}, "current_liabilities": {"value": 17027000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 296997000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 549000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": 288403000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 305430000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_liabilities": {"value": 16008000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 1019000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 17027000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 288403000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 305430000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 8433000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_assets": {"value": 5197000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "other_noncurrent_assets": {"value": 7884000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}}}, {"start_date": "2024-04-01", "end_date": "2024-06-30", "filing_date": "2024-08-13", "acceptance_datetime": "2024-08-13T20:15:23Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2024", "cik": "0001672619", "sic": "2834", "tickers": ["ELVN"], "company_name": "Enliven Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-096239", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-096239/files/elvn-20240630_htm.xml", "financials": {"income_statement": {"diluted_earnings_per_share": {"value": -0.41, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "diluted_average_shares": {"value": 48075035.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "nonoperating_income_loss": {"value": 4653000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_loss_from_continuing_operations_after_tax": {"value": -19950000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": -19950000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -19950000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 24603000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -24603000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_earnings_per_share": {"value": -0.41, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "basic_average_shares": {"value": 48075035.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "research_and_development": {"value": 18826000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_tax_expense_benefit": {"value": 232000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "other_operating_expenses": {"value": 5777000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss": {"value": -19950000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -19950000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -33665000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -52294000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 1806000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -33665000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -20435000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -52294000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 1806000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -20435000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "balance_sheet": {"cash": {"value": 312400000.0, "unit": "USD", "label": "Cash", "order": 210}, "current_assets": {"value": 318127000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 304932000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 630000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities": {"value": 22111000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 8916000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_assets": {"value": 5727000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "other_noncurrent_assets": {"value": 8286000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "accounts_payable": {"value": 1083000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "assets": {"value": 327043000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 21022000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 327043000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 22105000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 304932000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -86000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -20036000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -20036000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"start_date": "2024-01-01", "end_date": "2024-03-31", "filing_date": "2024-05-14", "acceptance_datetime": "2024-05-14T20:15:38Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2024", "cik": "0001672619", "sic": "2834", "tickers": ["ELVN"], "company_name": "Enliven Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-059573", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-059573/files/elvn-20240331_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": -194000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -22932000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -22932000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -22738000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "diluted_average_shares": {"value": 42045608.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": -22738000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_earnings_per_share": {"value": -0.54, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "other_operating_expenses": {"value": 6017000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "nonoperating_income_loss": {"value": 3249000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss": {"value": -22738000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -22738000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -25987000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -22738000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 25987000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "research_and_development": {"value": 19970000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_average_shares": {"value": 42045608.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "basic_earnings_per_share": {"value": -0.54, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -23361000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 49024000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 90270000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -23361000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 90270000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": -17885000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": -17885000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 49024000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "balance_sheet": {"assets": {"value": 342777000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 683000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 25065000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 22304000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 317712000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "accounts_payable": {"value": 2727000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_assets": {"value": 337199000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 342777000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "cash": {"value": 320500000.0, "unit": "USD", "label": "Cash", "order": 210}, "current_liabilities": {"value": 25031000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_assets": {"value": 16699000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "other_noncurrent_assets": {"value": 4895000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_assets": {"value": 5578000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 317712000.0, "unit": "USD", "label": "Equity", "order": 1400}}}}, {"start_date": "2023-10-01", "end_date": "2023-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2023", "cik": "0001672619", "sic": "2834", "tickers": ["ELVN"], "company_name": "Enliven Therapeutics, Inc.", "financials": {"balance_sheet": {"liabilities_and_equity": {"value": 271867000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 742000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_assets": {"value": 266151000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 245906000.0, "unit": "USD", "label": "Equity", "order": 1400}, "cash": {"value": 253100000.0, "unit": "USD", "label": "Cash", "order": 210}, "current_liabilities": {"value": 25894000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_assets": {"value": 13051000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "noncurrent_assets": {"value": 5716000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 25961000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 245906000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 4974000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_payable": {"value": 532000, "unit": "USD", "label": "Accounts Payable", "order": 710}, "assets": {"value": 271867000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 67000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_liabilities": {"value": 25362000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -19082000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 52502000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -19082000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"other_operating_expenses": {"value": 4824000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_expenses": {"value": 22729000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_earnings_per_share": {"value": -0.45999999999999974, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_after_tax": {"value": -19370000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_earnings_per_share": {"value": -0.45999999999999974, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "nonoperating_income_loss": {"value": 3359000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss_attributable_to_parent": {"value": -19370000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_average_shares": {"value": 1881148.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -19370000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_before_tax": {"value": -19370000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -22729000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss": {"value": -19370000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 17905000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "diluted_average_shares": {"value": 1881148.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}}, "cash_flow_statement": {"net_cash_flow": {"value": 26294000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 90000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -12482000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -12482000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 90000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 38686000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 38686000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 26294000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}}}, {"start_date": "2023-07-01", "end_date": "2023-09-30", "filing_date": "2023-11-09", "acceptance_datetime": "2023-11-09T21:15:39Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2023", "cik": "0001672619", "sic": "2834", "tickers": ["ELVN"], "company_name": "Enliven Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-062080", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-062080/files/elvn-20230930_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -20805000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -36000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -20805000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"other_operating_expenses": {"value": 4642000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss": {"value": -20769000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_earnings_per_share": {"value": -0.51, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "nonoperating_income_loss": {"value": 3479000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "basic_average_shares": {"value": 41030874.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_earnings_per_share": {"value": -0.51, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -20769000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -24248000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_average_shares": {"value": 41030874.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_parent": {"value": -20769000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 24248000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -20769000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 19606000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -20769000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -15894000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -15894000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -51868000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -51868000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -35549000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": -425000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": -425000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -35549000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "balance_sheet": {"equity": {"value": 261748000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 12293000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 268606000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 5435000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 214000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_assets": {"value": 5106000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "accounts_payable": {"value": 1493000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 10586000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 274041000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_assets": {"value": 4629000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 12079000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 261748000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "cash": {"value": 263500000.0, "unit": "USD", "label": "Cash", "order": 210}, "assets": {"value": 274041000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 806000, "unit": "USD", "label": "Fixed Assets", "order": 320}}}}, {"start_date": "2023-04-01", "end_date": "2023-06-30", "filing_date": "2023-08-10", "acceptance_datetime": "2023-08-10T20:16:58Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2023", "cik": "0001672619", "sic": "2834", "tickers": ["ELVN"], "company_name": "Enliven Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-041349", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-041349/files/elvn-20230630_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -12049000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -166387000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": -2820000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -166387000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -151518000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": -2820000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -12049000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": -151518000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 278994000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 288501000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_payable": {"value": 2843000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 9507000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "cash": {"value": 277900000.0, "unit": "USD", "label": "Cash", "order": 210}, "noncurrent_assets": {"value": 5326000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_noncurrent_assets": {"value": 4459000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 283175000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 278994000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 867000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_liabilities": {"value": 9147000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 288501000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_liabilities": {"value": 6304000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_assets": {"value": 5275000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}}, "income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -16721000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "nonoperating_income_loss": {"value": 3413000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss": {"value": -16721000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_before_tax": {"value": -16721000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -16721000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -16721000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_average_shares": {"value": 40961024.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "research_and_development": {"value": 15183000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_average_shares": {"value": 40961024.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_earnings_per_share": {"value": -0.41, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_earnings_per_share": {"value": -0.41, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_expenses": {"value": 20134000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -20134000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "other_operating_expenses": {"value": 4951000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -16832000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -111000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -16832000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2023-01-01", "end_date": "2023-03-31", "filing_date": "2023-05-11", "acceptance_datetime": "2023-05-11T20:16:19Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2023", "cik": "0001672619", "sic": "2834", "tickers": ["ELVN"], "company_name": "Enliven Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-021262", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-021262/files/elvn-20230331_htm.xml", "financials": {"balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 5082000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_assets": {"value": 4010000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "fixed_assets": {"value": 853000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_assets": {"value": 4863000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 10942000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 302866000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": 291416000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "accounts_payable": {"value": 5860000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 11450000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 291416000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 302866000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 298003000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 237441000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": 216566000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 237441000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -20844000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": -31000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": -31000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -20844000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 216566000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "income_statement": {"operating_expenses": {"value": 16418000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_earnings_per_share": {"value": -0.8, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_before_tax": {"value": -14724000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -14724000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_average_shares": {"value": 18514644.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_parent": {"value": -14724000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "diluted_earnings_per_share": {"value": -0.8, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -14724000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "research_and_development": {"value": 11880000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_average_shares": {"value": 18514644.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "other_operating_expenses": {"value": 4538000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": -14724000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_income_loss": {"value": -16418000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "nonoperating_income_loss": {"value": 1694000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -14724000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -14724000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}]